ArticleScientific reports2024

Mesenchymal-epithelial transition and AXL inhibitor TP-0903 sensitise triple-negative breast cancer cells to the antimalarial compound, artesunate.

Mirko Terragno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.